Artificial intelligence (AI), or machine learning, is an ancient concept based on the assumption that human thought and reasoning can be mechanized. In an era where rapid disease detection and response are critical, Artificial Intelligence (AI) offers unique opportunities to enhance disease surveillance. Traditional disease surveillance methods, often limited by manual data collection and slow reporting, can be significantly improved by AI’s ability to analyze vast amounts of data in real-time. AI-driven disease surveillance can predict outbreaks early, monitor disease spread, and provide timely information to health authorities, improving public health outcomes.
ENHANCING OUTBREAK PREDICTION
AI can help predict outbreaks, identify high-risk areas and monitor disease progression. Predicting disease outbreaks accurately and promptly is crucial for effective public health responses. Traditional methods of outbreak prediction often rely on historical data and manual reporting, which can be slow and reactive. AI can transform this landscape with its capacity to analyze vast amounts of real-time data from diverse sources such as social media, internet searches, and Electronic Health Records (EHRs). These sources provide real-time insights into disease trends, enabling AI to detect early signs of outbreaks. For instance, AI models can predict flu outbreaks one to two weeks earlier than traditional surveillance methods by combining data from search engines, social media, and traditional surveillance sources.[1]
Evidence suggests that Twitter data can be used to predict flu outbreaks by establishing a strong correlation between tweet volumes related to flu symptoms and actual outbreak data, indicating the potential of social media as an early warning system.[2] AI can also leverage Wikipedia data to monitor global disease activity by analyzing page views related to diseases and can provide valuable insights into outbreak patterns, highlighting the potential of unconventional data sources for disease surveillance.[3] Utilizing this early detection capability allows for timely preventive measures, reducing the spread and impact of diseases. AI can also assist in vaccine development by predicting how a virus or other causative agents will evolve and mutate over time. Researchers can use this data to develop targeted and effective vaccines.
MONITORING DISEASE SPREAD
Once an outbreak occurs, monitoring its spread is crucial for effective containment. AI can track disease transmission patterns in real-time, offering valuable insights into how and where diseases are spreading. The recent COVID-19 pandemic and infectious disease outbreaks have highlighted the importance of this technology. Predictions for future developments in infectious disease surveillance will include emerging technologies such as quantum computing, biosensors, augmented intelligence, and large language models, which can analyze large amounts of unstructured text, streamline labor-intensive processes, and identify trends in emerging infectious diseases. The importance of AI models in tracking the spread of COVID-19 using data from multiple sources, including travel patterns and social media, has already been proven.[4,5] This approach provided real-time mapping of the virus’s trajectory, aiding public health officials in their response efforts.
Studies have highlighted the effectiveness of AI in mapping the hidden geometry of contagion phenomena by modeling network-driven disease spread and providing a deeper understanding of how diseases propagate across different regions.[6] AI can enhance traditional epidemiological models by incorporating real-time data and advanced analytics. These models can simulate various scenarios, helping public health officials make informed decisions.
PROVIDING TIMELY ALERTS
AI not only predicts and monitors disease outbreaks but also disseminates critical information to healthcare providers and the public on a timely basis. By analyzing health data, AI systems can identify trends and anomalies, offering timely alerts about the emergence of a new disease or a resurgence of an existing one. This information can be quickly relayed to healthcare providers, enabling them to prepare and respond more effectively. The evidence shows how the AI system can analyze EHRs and other data sources to enhance the timeliness of disease reporting and how this system can significantly reduce delays in reporting infectious diseases, allowing for quicker public health responses.[7] AI can provide alerts by analyzing keyword surges on the web. Specialized search queries can also correct false alarms, improving the accuracy and reliability of web-based disease surveillance systems.[8]
OPTIMIZING RESOURCE ALLOCATION
AI can also optimize health resource allocation by analyzing data on disease prevalence, population demographics, and healthcare infrastructure. AI can develop optimization algorithms that allocate resources such as vaccines, medications, and medical equipment to areas based on current and projected needs. AI-driven resource allocation minimizes waste and ensures that resources are used where they have the most impact. This efficiency translates into significant cost savings, especially in resource-constrained settings.
The convergence of advanced algorithms, big data analytics, and machine learning techniques has empowered health care companies to extract insights from vast datasets, that can lead to more accurate diagnostics, personalized treatment plans, and enhanced patient outcomes. AI research has become an established academic discipline within philosophy, mathematics, engineering, physics, and the biological sciences, with debate regarding its potential uses and hazards. Brandeau et al.[9] (2009) discussed the importance of modeling disaster responses in public health. Their position paper recommended AI-based approaches for optimizing resource allocation during public health emergencies. For instance, AI has been used to forecast the demand for hospital beds and ventilators during the COVID-19 pandemic.[10]
CHALLENGES
Although AI offers numerous benefits, it also raises ethical and privacy concerns. The use of AI in public health surveillance involves handling sensitive health data. Protecting the privacy and security of this data is paramount. Robust legal and technical measures must be in place to safeguard personal information and prevent misuse. Pieces of evidence on the ethical challenges of machine learning in medicine highlighted a need for transparency, accountability, and safeguards to protect individual privacy in AI-driven health initiatives.[11] In addition, the accuracy of AI models depends on the quality of the data they are trained on. Biases in the data can lead to inaccurate predictions and unequal health outcomes.[12] Developing transparent and unbiased AI models is essential for reliable disease surveillance. AI has now become an established technology in all areas of medicine. The ethical and privacy concerns should be recognized and addressed with the development of guidelines for AI use. Therefore, AI-driven approaches complement human-curated ones, including traditional public health surveillance. The field of AI in clinical medicine is evolving. However, despite its many limitations and concerns, AI may bring the most apparent medical benefits in diagnosis and infectious disease surveillance.
Thus, AI has the potential to transform disease surveillance by enhancing outbreak prediction, monitoring disease spread, providing timely information, and optimizing resource allocation. However, addressing ethical and privacy concerns is crucial to fully realizing the benefits of AI in public health. With careful implementation and oversight, AI can become indispensable in safeguarding public health and improving disease surveillance systems worldwide.
REFERENCES
- 1.Santillana M, Nguyen AT, Dredze M, Paul MJ, Nsoesie EO, Brownstein JS. Combining search, social media, and traditional data sources to improve influenza surveillance. PLoS Comput Biol. 2015;11:e1004513. doi: 10.1371/journal.pcbi.1004513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gesualdo F, Stilo G, Agricola E, Gonfiantini MV, Pandolfi E, Velardi P, et al. Influenza-like illness surveillance on twitter through automated learning of naïve language. PLoS One. 2013;8:e82489. doi: 10.1371/journal.pone.0082489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Generous N, Fairchild G, Deshpande A, Valle SYD, Priedhorsky R. Global disease monitoring and forecasting with wikipedia. PLoS Comput Biol. 2014;10:e1003892. doi: 10.1371/journal.pcbi.1003892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Xu B, Gutierrez B, Mekaru S, Sewalk K, Goodwin L, Loskill A, et al. Epidemiological data from the COVID-19 outbreak, real-time case information. Sci Data. 2020;7:106. doi: 10.1038/s41597-020-0448-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Piccialli F, Cola VS di, Giampaolo F, Cuomo S. The role of artificial intelligence in fighting the COVID-19 pandemic. Inf Syst Front. 2021;23:1467. doi: 10.1007/s10796-021-10131-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Brockmann D, Helbing D. The hidden geometry of complex, network-driven contagion phenomena. Science. 2013;342:1337–42. doi: 10.1126/science.1245200. [DOI] [PubMed] [Google Scholar]
- 7.Ramos PIP, Marcilio I, Bento AI, Penna GO, Oliveira JF de, Khouri R, et al. Combining digital and molecular approaches using health and alternate data sources in a next-generation surveillance system for anticipating outbreaks of pandemic potential. JMIR Public Health Surveill. 2024;10:e47673. doi: 10.2196/47673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Choi J, Cho Y, Shim E, Woo H. Web-based infectious disease surveillance systems and public health perspectives: A systematic review. BMC Public Health. 2016;16:1238. doi: 10.1186/s12889-016-3893-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Brandeau ML, McCoy JH, Hupert N, Holty JE, Bravata DM. Recommendations for modeling disaster responses in public health and medicine: A position paper of the society for medical decision making. Med Decis Mak Int J Soc Med Decis Mak. 2009;29:438–60. doi: 10.1177/0272989X09340346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ortiz-Barrios M, Arias-Fonseca S, Ishizaka A, Barbati M, Avendaño-Collante B, Navarro-Jiménez E. Artificial intelligence and discrete-event simulation for capacity management of intensive care units during the Covid-19 pandemic: A case study. J Bus Res. 2023;160:113806. doi: 10.1016/j.jbusres.2023.113806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vayena E, Blasimme A, Cohen IG. Machine learning in medicine: Addressing ethical challenges. PLoS Med. 2018;15:e1002689. doi: 10.1371/journal.pmed.1002689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366:447–53. doi: 10.1126/science.aax2342. [DOI] [PubMed] [Google Scholar]